Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • DMCH
    Junior Member
    • Aug 2011
    • 2

    Velvet Assembler: expected coverage versus estimated coverage versus effective covera

    Hello everyone,

    I am very new to bioinformatics in general, and I am trying to assemble some short reads using velvet. Having read the manual, I am still not clear on the distinction between some of the coverage terms.

    Specifically, is the expected coverage the length weighted node or contig or kmer coverage?

    Is the estimated coverage actually referring to an estimate of the expected coverage, performed by velvet?

    Is the effective coverage the node coverage after errors have been removed using the coverage cutoff? Or is it an estimate of the proportion of the genome length that is covered by the assembled contigs?

    Finally, is there a difference between the coverage depth, and the coverage density? Are both these values expressed in units of 'X'? e.g. 5X coverage.

    Many thanks indeed for any help. This is really frustrating me!
  • SES
    Senior Member
    • Mar 2010
    • 275

    #2
    Velvet coverage is not x-based. The coverage you are getting is k-mer coverage per contig. I know this question has been asked before, so I won't go into any detail. Some quick google searches should get you the answers you are looking for.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...